Sounds like a terrible experience
Yes nobody would get a central line if they had a choice - not only is it very painful it comes with serious risks. Sometimes central lines are unavoidable, but if you want to maximise the commercial potential of your drug you would do everything you can to enable peripheral IV infusion instead.
- Forums
- ASX - By Stock
- RAC - Charts & Price Action
Sounds like a terrible experience :( Yes nobody would get a...
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.45 |
Change
0.030(2.11%) |
Mkt cap ! $247.1M |
Open | High | Low | Value | Volume |
$1.43 | $1.45 | $1.40 | $163.8K | 115.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $1.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.45 | 31396 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 1.440 |
1 | 11250 | 1.390 |
1 | 1000 | 1.380 |
1 | 5000 | 1.370 |
1 | 1279 | 1.365 |
Price($) | Vol. | No. |
---|---|---|
1.450 | 31396 | 1 |
1.480 | 3055 | 2 |
1.500 | 17040 | 2 |
1.520 | 6000 | 1 |
1.575 | 2000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online